THYROCARE TECHNOLOGIES
Back to Cashflow Statement
|
THYROCARE TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-130 Cr | ₹-85 Cr | ₹-86 Cr | ₹-89 Cr | ₹-62 Cr |
What is the latest Cash Flow from Financing Activities ratio of THYROCARE TECHNOLOGIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-130 Cr |
Mar2024 | ₹-85 Cr |
Mar2023 | ₹-86 Cr |
Mar2022 | ₹-89 Cr |
Mar2021 | ₹-62 Cr |
How is Cash Flow from Financing Activities of THYROCARE TECHNOLOGIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-130 Cr | Negative | |
Mar2024 | ₹-85 Cr | Negative | |
Mar2023 | ₹-86 Cr | Negative | |
Mar2022 | ₹-89 Cr | Negative | |
Mar2021 | ₹-62 Cr | - |
Compare Cash Flow from Financing Activities of peers of THYROCARE TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
THYROCARE TECHNOLOGIES | ₹7,152.4 Cr | 0.8% | 22% | 67.7% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹122,695.0 Cr | -0.7% | 3.6% | 42.2% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹104,051.0 Cr | -0.3% | 0.9% | 8.5% | Stock Analytics | |
FORTIS HEALTHCARE | ₹70,328.1 Cr | 6.2% | 20.5% | 83.4% | Stock Analytics | |
GLOBAL HEALTH | ₹37,086.4 Cr | 4.4% | 6.2% | 21% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹37,031.2 Cr | -2.1% | -11.8% | 41.8% | Stock Analytics |
THYROCARE TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
THYROCARE TECHNOLOGIES | 0.8% |
22% |
67.7% |
SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses